Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis

被引:0
|
作者
Yan Wei
Peng Li-Ying
Ban Cheng-Jun
Xu Xue-Feng
Zhu Min
Liu Yan
Zhang Shu
Zhai Zhen-Guo
Wang Chen
Dai Hua-Ping
机构
[1] Capital Medical University
[2] Department of Respiratory and Critical Care Medicine
[3] Beijing Chao-Yang Hospital
[4] China
[5] Beijing Institute of Respiratory Medicine
[6] Beijing Key Laboratory of Respiratory and Pulmonary Circulation
[7] Beijing 100020
基金
国科技部“十一五”科技计划项目;
关键词
Idiopathic Pulmonary Fibrosis; Incidence; Pulmonary Hypertension;
D O I
暂无
中图分类号
R544.1 [高血压];
学科分类号
摘要
Background: Pulmonary hypertension (PH) frequently complicates the course of idiopathic pulmonary fibrosis (IPF) patients and is associated with significantly worse outcomes. The aim of the present study was to investigate the incidence of PH in IPF patients and evaluate the correlation between clinical parameters and systolic pulmonary artery pressure (sPAP).Methods: Hospitalized patients with IPF, who were evaluated for sPAP by Doppler echocardiography from January 2004 to December 2011, were enrolled in our study. Patients were defined as PH by an estimated sPAP > 50 mmHg and graded as PH likely, PH possible and PH unlikely, based on the 2009 European Society of Cardiology/European Respiratory Society PH Guidelines. The correlations between clinical parameters and sPAP were analyzed by multiple linear regression.Results: Totally, 119 IPF patients were enrolled in our study and 28 (23.5%), 20 (16.8%) and 71 (59.7%) patients were PH likely, PH possible and PH unlikely, respectively. Borg dyspnea score was positively correlated with sPAP,r = 0.467,P < 0.001. Oxygen saturation was negatively correlated with sPAP,r = ?0.416,P < 0.001. Diffusing capacity of the lung for carbon monoxide percentage predicted was negatively correlated with sPAP,r = ?0.424,P = 0.003. N-terminal fragment of pro-brain natriuretic peptide and pulmonary artery width was positively correlated with sPAP,r = 0.452,P = 0.011 andr = 0.513,P < 0.001, respectively.Conclusions: The incidence of PH in IPF patients was 23.5% in a single center of China. PH may worsen the dyspnea, right heart dysfunction and decrease the life quality of the patients with IPF.
引用
收藏
页码:896 / 901
页数:6
相关论文
共 50 条
  • [1] Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
    Yan, Wei
    Peng, Li-Ying
    Ban, Cheng-Jun
    Xu, Xue-Feng
    Zhu, Min
    Liu, Yan
    Zhang, Shu
    Zhai, Zhen-Guo
    Wang, Chen
    Dai, Hua-Ping
    CHINESE MEDICAL JOURNAL, 2015, 128 (07) : 896 - 901
  • [2] Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
    Nadrous, HF
    Pellikka, PA
    Krowka, MJ
    Swanson, KL
    Chaowalit, N
    Decker, P
    Ryu, JH
    CHEST, 2004, 126 (04) : 771S - 771S
  • [3] Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
    Nadrous, HF
    Pellikka, PA
    Krowka, MJ
    Swanson, KL
    Chaowalit, N
    Decker, PA
    Ryu, JH
    CHEST, 2005, 128 (04) : 2393 - 2399
  • [4] Impact of pulmonary hypertension in baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
    Arvanitaki, Alexandra
    Diller, Gerhard
    Kouranos, Vasileios
    Semple, Thomas
    Li, Wei
    Mccabe, Colm
    Gatzoulis, Michael A.
    Wort, John
    Price, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [5] Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
    Ohkubo, Hirotsugu
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Niimi, Akio
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY HYPERTENSION
    Collins, Ashley
    King, Christopher
    Shlobin, Oksana
    Nathan, Steven
    CHEST, 2020, 158 (04) : 1071A - 1072A
  • [7] Clinical Characteristics Of Patients With Advanced Idiopathic Pulmonary Fibrosis
    de Andrade, J. A.
    Whelan, T.
    Luckhardt, T.
    Lancaster, L. H.
    Gamerman, V.
    Kulkarni, T.
    Neely, M. L.
    Yow, E.
    O'Brien, E.
    Conoscenti, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis
    Callahan, Sean J.
    Xia, Meng
    Murray, Susan
    Flaherty, Kevin R.
    RESPIRATORY MEDICINE, 2016, 119 : 96 - 101
  • [9] PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS: PREVALENCE AND CLINICAL PROGRESS
    Castria, D.
    Refini, R. M.
    Bargagli, E.
    Mezzasalma, F.
    Pierli, C.
    Rottoli, P.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (03) : 681 - 689
  • [10] Pulmonary hypertension in idiopathic pulmonary fibrosis: Epidemiology and clinical correlates
    Shorr, AF
    Cors, C
    Lettieri, CJ
    Helman, DL
    Nathan, SD
    CHEST, 2005, 128 (04) : 218S - 218S